Chapter 7. Antagonists of VILA-4

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Annual Reports in Medicinal Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0065-7743(02)37008-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiogenesis induced by tumor necrosis factor-agr; is mediated by α4 integrins

  2004cited by this paper
• A 3D Structure Model of Integrin α4β1 Complex: I. Construction of a Homology Model of β1 and Ligand Binding Analysis

  2002cited by this paper
• Effects of VLA-4 antagonists in rat whole embryo culture.

  2002cited by this paper
• Crystal Structure of the Extracellular Segment of Integrin αVβ3 in Complex with an Arg-Gly-Asp Ligand

  2002cited by this paper
• Substituted N-(3,5-dichlorobenzenesulfonyl)-L-prolyl-phenylalanine analogues as potent VLA-4 antagonists.

  2002cited by this paper
• Inhibition of LFA‐1/ICAM‐1 and VLA‐4/VCAM‐1 as a therapeutic approach to inflammation and autoimmune diseases

  2002cited by this paper
• Inhibition of TNF-α–induced Sickle RBC Retention in Retina by a VLA-4 Antagonist

  2001cited by this paper
• Imide and lactam derivatives of N-benzylpyroglutamyl-L-phenylalanine as VCAM/VLA-4 antagonists.

  2001cited by this paper
• A major role for VCAM-1, but not ICAM-1, in early atherosclerosis.

  2001cited by this paper
• Discovery and evaluation of potent, cysteine-based α4β1 integrin antagonists

  2000cited by this paper
• The genetics of asthma. The important questions.

  2000cited by this paper
• Chapter 7. Recent Approaches Towards Inhibiting Allergic Eosinophilia

  1999cited by this paper
• Chapter 18. Inhibitors of Integrin Alpha 4 Beta 1 (VLA-4)

  1999cited by this paper
• A cyclic hexapeptide is a potent antagonist of alpha 4 integrins.

  1997cited by this paper
• Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation

  1996cited by this paper
• Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation.

  1995cited by this paper
• Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts.

  1995cited by this paper
• A novel β1‐dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration

  1995cited by this paper
• Sickle reticulocytes adhere to VCAM-1.

  1995cited by this paper
• Cell adhesion events mediated by alpha 4 integrins are essential in placental and cardiac development.

  1995cited by this paper
• Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice.

  1995cited by this paper
• Protection Against Adoptive Transfer of Autoimmune Diabetes Mediated Through Very Late Antigen-4 Integrin

  1994cited by this paper
• Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep.

  1994cited by this paper
• Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment.

  1994cited by this paper
• The pathogenesis of adoptive murine autoimmune diabetes requires an interaction between alpha 4-integrins and vascular cell adhesion molecule-1.

  1994cited by this paper
• A novel cyclic pentapeptide inhibits alpha 4 beta 1 and alpha 5 beta 1 integrin-mediated cell adhesion.

  1993cited by this paper
• Alpha 4 beta 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium

  1993cited by this paper
• Integrin alpha 4 beta 1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia

  1993cited by this paper
• Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody.

  1993cited by this paper
• Monoclonal antibodies to the integrin α−4 subunit inhibit the murine contact hypersensitivity response

  1993cited by this paper
• Integrins: versatility, modulation, and signaling in cell adhesion.

  1992cited by this paper
• Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin

  1992cited by this paper
• Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis.

  1991cited by this paper
• Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules

  1991cited by this paper
• VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

  1990cited by this paper
• Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin

  1989cited by this paper
• Characterization of the cell surface heterodimer VLA-4 and related peptides.

  1987cited by this paper

• 4-(Pyrrolidinyl)methoxybenzoic acid derivatives as a potent, orally active VLA-4 antagonist.

  2006cites this paper
• Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonist.

  2005cites this paper